Results 101 to 110 of about 2,233 (157)

Exploring type 2 inflammation and disease complexity: perspectives of a clinical immunologist. [PDF]

Front Immunol
Tal Y, Rubin L, Munitz A, Adini I.
europepmc   +1 more source

Twelve-Month Real-World Outcomes of Tezepelumab in Severe Asthma: Clinical Remission, Biomarker Changes, and Trigger Burden-A SANI Multicenter Cohort. [PDF]

J Pers Med
Nicola S, Negrini S, Ribolla F, Guida G, Rinaldo RF, Bondi B, Badiu I, Corradi F, Quinternetto A, Vitali I, Lo Sardo L, Crida B, Mhimid L, Tocci SL, Teocchi M, Milione A, Marengo M, Heffler E, Canonica GW, Blasi F, Paggiaro P, Boem M, Basiglio S, Alessi L, Braido F, Ricciardolo FLM, Solidoro P, Bagnasco D, Brussino L, On Behalf Of The Sani Study Group.   +29 more
europepmc   +1 more source

Influence of PAI-1 gene polymorphism on the effectiveness of tezepelumab in individuals with severe asthma: a study protocol for a prospective, non-randomized, interventional, comparative trial. [PDF]

J Thorac Dis
Fukahori S, Obase Y, Fukushima C, Kosai K, Yanagihara K, Hara S, Tomari S, Tsubouchi H, Miyazaki T, Matsuo N, Matsuo A, Matsumoto N, Ide H, Tobino K, Kodaka N, Matsuse H, Arakaki W, Haranaga S, Yamamoto K, Yoshimine H, Sakakibara H, Yatera K, Tashiro H, Takahashi K, Himeji D, Mukae H.   +25 more
europepmc   +1 more source

Tezepelumab in Patients With Severe Asthma: Response at 3 Months

Journal of Investigational Allergy and Clinical Immunology
J C, Miralles-López, R, Andújar-Espinosa, F J, Bravo-Gutierrez, S, Cabrejos-Perotti, M, Ramírez-Hernández, C, Díaz-Chantar, M J, Pajarón Fernández, J, Valverde-Molina, V, Pérez-Fernández   +8 more
openaire   +2 more sources

Monoclonal antibody therapy in patients with severe asthma and COPD: rethinking treatment pathways and success. [PDF]

BMJ Open Respir Res
Burton R, Puthoor M, Fyles F, Lewis L, Joplin H, Burhan H.   +5 more
europepmc   +1 more source

Clinical Benefits of Tezepelumab in a Real-World Cohort of Patients With Severe Uncontrolled Asthma in Castilla-La Mancha, Spain. [PDF]

Open Respir Arch
Bujalance-Cabrera C, Espinosa de Los Monteros-Garde MJ, Morena-Vallés D, Godoy-Mayoral R, Bravo-Nieto JM, Jiménez-Arroyo M, Jiménez-López J, Lázaro-Polo FJ, Izquierdo-Alonso JL.   +8 more
europepmc   +1 more source

Asthma and Sinonasal Diseases: Shared Clinical Comorbidities, Inflammatory Pathways and Management Strategies. [PDF]

Med Sci (Basel)
Cefaloni F, Schiavi E, Morviducci M, De Corso E, Brunori M, Masieri S, Bonini M.   +6 more
europepmc   +1 more source

The Use of Biological Therapies in the Treatment of Chronic Rhinosinusitis with Nasal Polyps: Current State of Knowledge. [PDF]

J Clin Med
Wrona J, Krupa Z, Zawadzka M, Rydzek J, Muzyka A, Dorobisz K, Pazdro-Zastawny K.   +6 more
europepmc   +1 more source

Targeting the Epithelial Alarmin Pathway with Tezepelumab in Highly Comorbid, Biologic-Experienced Severe Asthma: 52-Week Real-World Outcomes. [PDF]

J Clin Med
González-Pérez R, De Lorenzo-García I, Izaguirre-Flores H, González-Expósito H, García Gil S, Poza-Guedes P.   +5 more
europepmc   +1 more source

Galectin-10 and Charcot-Leyden Crystals in Chronic Rhinosinusitis with Nasal Polyps: Pathogenetic Insights and Clinical Implications. [PDF]

Diagnostics (Basel)
Kamiński B, Ochab D, Kopczyński J, Łacwik P, Pałczyński C.   +4 more
europepmc   +1 more source